These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 33009062)

  • 21. Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study.
    Koloski NA; Jones M; Young M; Talley NJ
    Aliment Pharmacol Ther; 2015 May; 41(9):856-66. PubMed ID: 25736433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis.
    Oka P; Parr H; Barberio B; Black CJ; Savarino EV; Ford AC
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):908-917. PubMed ID: 32702295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presentation and Characteristics of Abdominal Pain Vary by Irritable Bowel Syndrome Subtype: Results of a Nationwide Population-Based Study.
    Shah ED; Almario CV; Spiegel BM; Chey WD
    Am J Gastroenterol; 2020 Feb; 115(2):294-301. PubMed ID: 31913193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom.
    Palsson OS; Whitehead W; Törnblom H; Sperber AD; Simren M
    Gastroenterology; 2020 Apr; 158(5):1262-1273.e3. PubMed ID: 31917991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparisons of the Rome III and Rome IV criteria for diagnosis of irritable bowel syndrome in Indian and Bangladeshi communities and internal shifts in the diagnostic categories of bowel disorders of gut-brain interactions.
    Ghoshal UC; Rahman MM; Pratap N; Misra A; Sarker SA; Hasan M; Bangdiwala SI; Palsson OS; Sperber AD
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14579. PubMed ID: 37010834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 12 months of longitudinal follow-up.
    Barberio B; Fairbrass KM; Gracie DJ; Ford AC
    Neurogastroenterol Motil; 2024 Feb; 36(2):e14713. PubMed ID: 37994228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator.
    Drossman DA; Morris CB; Hu Y; Toner BB; Diamant N; Leserman J; Shetzline M; Dalton C; Bangdiwala SI
    Gastroenterology; 2005 Mar; 128(3):580-9. PubMed ID: 15765393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.
    Vork L; Weerts ZZRM; Mujagic Z; Kruimel JW; Hesselink MAM; Muris JWM; Keszthelyi D; Jonkers DMAE; Masclee AAM
    Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28804974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review.
    Guilera M; Balboa A; Mearin F
    Am J Gastroenterol; 2005 May; 100(5):1174-84. PubMed ID: 15842596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype.
    Mearin F; Balboa A; Badía X; Baró E; Caldwell E; Cucala M; Díaz-Rubio M; Fueyo A; Ponce J; Roset M; Talley NJ
    Eur J Gastroenterol Hepatol; 2003 Feb; 15(2):165-72. PubMed ID: 12560761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Splitting irritable bowel syndrome: from original Rome to Rome II criteria.
    Mearin F; Roset M; Badía X; Balboa A; Baró E; Ponce J; Díaz-Rubio M; Caldwell E; Cucala M; Fueyo A; Talley NJ
    Am J Gastroenterol; 2004 Jan; 99(1):122-30. PubMed ID: 14687153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognosis of patients with Rome IV-defined versus physician-diagnosed irritable bowel syndrome: Longitudinal follow-up study.
    Goodoory VC; Craig OF; Gracie DJ; Black CJ; Ford AC
    Neurogastroenterol Motil; 2022 Jun; 34(6):e14282. PubMed ID: 34612560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
    Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B
    World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
    Ersryd A; Posserud I; Abrahamsson H; Simrén M
    Aliment Pharmacol Ther; 2007 Sep; 26(6):953-61. PubMed ID: 17767480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Manning, Rome I, II, and III, and Asian diagnostic criteria: report of the Multicentric Indian Irritable Bowel Syndrome (MIIBS) study.
    Ghoshal UC; Abraham P; Bhatia SJ; Misra SP; Choudhuri G; Biswas KD; Chakravartty K; Dadhich S; Goswami BD; Jayanthi V; Kumar S; Koshy A; Kumar KR; Makharia G; Nijhawan S; Pratap N; Ray G; Sachdeva S; Singh SP; Thomas V; Udawat H
    Indian J Gastroenterol; 2013 Nov; 32(6):369-75. PubMed ID: 23999682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria.
    Shiha MG; Asghar Z; Thoufeeq M; Kurien M; Ball AJ; Rej A; Tai FWD; Afify S; Aziz I
    Neurogastroenterol Motil; 2021 Oct; 33(10):e14121. PubMed ID: 33719130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Rome IV criteria on the prevalence of post-infection irritable bowel syndrome.
    Breen-Lyles M; Decuir M; Byale A; Smith K; Grover M
    Neurogastroenterol Motil; 2023 May; 35(5):e14532. PubMed ID: 36633303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irritable bowel syndrome subtypes defined by Rome II and Rome III criteria are similar.
    Dorn SD; Morris CB; Hu Y; Toner BB; Diamant N; Whitehead WE; Bangdiwala SI; Drossman DA
    J Clin Gastroenterol; 2009 Mar; 43(3):214-20. PubMed ID: 19623100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.
    Shekhar C; Monaghan PJ; Morris J; Issa B; Whorwell PJ; Keevil B; Houghton LA
    Gastroenterology; 2013 Oct; 145(4):749-57; quiz e13-4. PubMed ID: 23872499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome.
    Wong RK; Palsson OS; Turner MJ; Levy RL; Feld AD; von Korff M; Whitehead WE
    Am J Gastroenterol; 2010 Oct; 105(10):2228-34. PubMed ID: 20502449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.